Select Publications
Preprints
2024, Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic, http://dx.doi.org/10.1101/2024.08.12.24311730
,2023, Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach, http://dx.doi.org/10.1101/2023.01.03.23284131
,2023, Impact of 100 Days Vaccination Mission on COVID-19: A Mathematical Modelling Study, http://dx.doi.org/10.2139/ssrn.4519550
,2023, Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling study, http://dx.doi.org/10.1101/2023.02.09.23285743
,2023, Modelling the impact of hybrid immunity on future COVID-19 epidemic waves, http://dx.doi.org/10.1101/2023.03.12.23287174
,2022, The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa., http://dx.doi.org/10.1101/2022.03.12.22271872
,2022, The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant, http://dx.doi.org/10.1101/2022.01.17.22269222
,2022, Quantifying the impact of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study, http://dx.doi.org/10.1101/2022.08.08.22278528
,2021, Quantifying the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic, http://dx.doi.org/10.21203/rs.3.rs-343127/v1
,2021, The costs of keeping schools open during the COVID-19 pandemic, http://dx.doi.org/10.21203/rs.3.rs-283318/v1
,2021, Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: a mathematical modelling analysis, http://dx.doi.org/10.1101/2021.03.19.21253960
,2020, Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage, http://dx.doi.org/10.1101/2020.10.09.20209973
,Long Term Vaccination Strategies to Mitigate the Global Impact of SARS-CoV-2 Transmission: A Modelling Study, http://dx.doi.org/10.2139/ssrn.4135323
,Modelling the Age-Specific Risk of Hospitalisation Due to RSV Infection, http://dx.doi.org/10.2139/ssrn.4654754
,